Is Sentinel Lymph Node Biopsy Appropriate in Patients With Thin Melanomas: Too Early To Tell?

[1]  D. Coit,et al.  Results of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma , 2006, Annals of Surgical Oncology.

[2]  J. Lang.  Mitotic Rate as a Predictor of Sentinel Lymph Node Positivity in Patients With Thin Melanomas , 2006 .

[3]  L. Talve,et al.  Sentinel node metastasectomy in thin ≤1-mm melanoma , 2005, Langenbeck's Archives of Surgery.

[4]  R. Elashoff,et al.  Interim results of the Multicenter Selective Lymphadenectomy Trial (MSLT-I) in clinical stage I melanoma , 2005 .

[5]  I. Tannock,et al.  The prognostic effect of lipids on early-stage breast cancer (BC) outcome , 2005 .

[6]  A. Alavi,et al.  Mitotic Rate as a Predictor of Sentinel Lymph NodePositivity in Patients With Thin Melanomas , 2004, Annals of Surgical Oncology.

[7]  Jeremy MG Taylor,et al.  Mitotic Rate and Younger Age Are Predictors of Sentinel Lymph Node Positivity: Lessons Learned From the Generation of a Probabilistic Model , 2004, Annals of Surgical Oncology.

[8]  M. Walker,et al.  Cost-effectiveness of sentinel lymph node biopsy in thin melanomas. , 2003, Surgery.

[9]  W. McCarthy,et al.  Prognosis for patients with thin cutaneous melanoma , 2003, Cancer.

[10]  A. Dobozy,et al.  Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas , 2003, The British journal of dermatology.

[11]  R. Lyles,et al.  Sentinel Lymph Node Mapping for Thick (≥4-mm) Melanoma: Should We Be Doing It? , 2003, Annals of Surgical Oncology.

[12]  N. Cascinelli,et al.  Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial , 1998, The Lancet.